BJ
SAGE

BlackRock Japan’s Sage Therapeutics SAGE Stock Holding History

BlackRock Japan’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$11K Buy
221
+77
+53% +$3.63K ﹤0.01% 1210
2016
Q3 		$7K Buy
+144
New +$5.86K ﹤0.01% 1237
2015
Q3 		– Sell
-1,575
Closed -$115K – 1342
2015
Q2 		$115K Sell
1,575
-837
-35% -$53.8K ﹤0.01% 950
2015
Q1 		$121K Buy
2,412
+1,917
+387% +$82.4K ﹤0.01% 937
2014
Q4 		$18K Buy
495
+93
+23% +$3.47K ﹤0.01% 1223
2014
Q3 		$13K Buy
+402
New +$11.6K ﹤0.01% 1193

Other funds holding SAGE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
ORI
Oak Ridge Investments Chicago, Illinois $1.51B AUM 37.25% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return